Repay (RPAY) Q4 2025 Earnings Transcript

Repay reported Q4 revenue of $78.6 million and gross profit of $58.3 million, with normalized growth of 10% and 9% respectively, while adjusted EBITDA was $32.4 million at a 41% margin and free cash flow was $13.8 million. Management guided 2026 revenue to $340 million-$346 million and adjusted EBITDA to $136.5 million-$141.5 million, implying 10%-12% reported growth and over 45% free cash flow conversion. The company also highlighted AI-driven automation, stronger business payments momentum, and $23 million remaining under its buyback authorization, partly offset by a $138.9 million goodwill impairment and higher interest expense from January refinancing.

Analysis

RPAY’s setup is better than the headline growth rate implies because the mix shift is doing two jobs at once: it is improving resilience in core payments while the political-media business becomes an explicit cyclical kicker rather than a crutch. That matters for valuation because the market typically discounts payment processors on perceived durability; if management can keep normalized growth in the high single digits while layering in a midterm-driven revenue step-up in the back half, the multiple can expand before the election flow even arrives.

The more important second-order effect is on operating leverage. The business payments engine appears to be crossing a threshold where supplier-network scale, float income, and higher total-pay adoption reinforce each other, which should keep gross profit growth ahead of reported revenue even after the election tailwind rolls off. The flip side is that the current year’s guide is partially front-loaded with implementation slippage, so Q1 is likely to be the low point; that creates a cleaner trade setup if the stock weakens into the print or on any near-term disappointment around go-lives.

The balance-sheet move is also underappreciated: drawing revolver to retire zero-coupon converts is economically sensible only if management believes organic growth and cash generation can outrun the incremental interest burden. That creates a “prove-it” year, but it also sets up optionality for buybacks or small M&A if execution holds. The main tail risk is that AI/automation savings arrive later than promised while enterprise implementations slip again, which would compress confidence in the 2027 acceleration story and leave the stock exposed to de-rating despite decent current-year numbers.

Key Decisions for Investors

• Long RPAY on weakness over the next 1-3 weeks if the market prices Q1 deceleration as structural rather than timing-driven; target a 12-18% upside move into the second-half election narrative, with downside limited if normalized growth holds above mid-single digits.
• Buy RPAY call spreads into any post-earnings pullback: 6-9 month tenor, struck around a 15-20% upside move, to express the view that margins and political-media revenue reaccelerate in H2 without overpaying for near-term volatility.
• Pair trade: long RPAY / short a lower-growth payments compounder with similar valuation multiple if the market is not rewarding growth re-acceleration; the relative thesis is that RPAY has a clearer 2H catalyst stack (political media + operating leverage + capital return optionality).
• If holding RPAY, hedge the execution risk with a small short-dated put position into the next quarter: the stock is vulnerable to another implementation-delay headline, but that risk should fade if management shows any evidence of pipeline conversion.
• Watch for a secondary buy point if the stock sells off on revolver draw headlines; that financing move is more about liability management than distress, so any 5-10% indiscriminate drop would likely be a favorable entry for a 6-12 month trade.